Purpose
To examine the preliminary efficacy of Cognitive Retraining and Functional Treatment (CRAFT) combining remote computerized cognitive training (CCT) and occupation-based treatment in adults with cancer-related cognitive impairment (CRCI).
Methods
Three-armed randomized controlled trial including 74 individuals with CRCI, randomized into 12 weeks of either CRAFT, CCT alone, or treatment-as-usual. Assessments evaluating participation in daily life, perceived cognition, cognitive performance, quality-of-life, and treatment satisfaction were administered at baseline, post-intervention, and 3-month follow-up.
Results
Significant time × group interactions in favor of the CRAFT and CCT groups were found for participation in daily life (
F
2,34
= 5.31,
p
= .01, eta = .238), perceived cognition (
F
2,34
= 4.897,
p
= .014, eta = .224), and cognitive performance on speed of processing test (
F
= 5.678,
p
= .009, eta = .289). The CRAFT group demonstrated significantly larger clinically meaningful gains on participation in daily life (chi-square = 6.91,
p
= .032) and significantly higher treatment satisfaction. All treatment gains were maintained at a 3-month follow-up (
n
= 32).
Conclusions
CCT and CRAFT were found to have a positive impact on participation and cognitive outcomes among individuals with CRCI. The CRAFT showed an additional advantage in improving self-chosen occupation-based goals suggesting that a combination of cognitive training with occupation-based intervention has a positive synergistic effect resulting in “real world” health benefits.
Implications for cancer survivors
A combination of cognitive training with occupation-based intervention has a positive effect resulting in clinically meaningful improvements in participation in daily life, objective cognitive performance, and subjective cognitive impairment.
Clinical trial registration: ClinicalTrials.gov NCT04210778, December 26, 2019, retrospectively registered.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00520-023-07611-y.